CIBC Asset Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,430
Closed -$632K 1281
2020
Q3
$632K Buy
7,430
+183
+3% +$9.25K ﹤0.01% 665
2020
Q2
$257K Buy
+7,247
New +$212K ﹤0.01% 852

CIBC Asset Management's IMMU Position: Q4 2020 in Review

CIBC Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 7,430 shares — an estimated $632K sold.

CIBC Asset Management first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $632K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • CIBC Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • CIBC Asset Management sold 7,430 Immunomedics Inc shares in Q4 2020, an estimated $632K.
  • CIBC Asset Management first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • CIBC Asset Management's Immunomedics Inc position peaked at $632K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on CIBC Asset Management's 13F filing for Q4 2020, filed 3 Feb 2021.